BIOCON LTD. - 532523 - Announcement Under Regulation 30 (LODR)
Meeting conducted with Institutional Investors/Research Analysts21-03-2024
21-03-2024
Stock to sell today: Biocon (247)
The chart shows that the price could drop to 240 in a day or two21-03-2024
BIOCON LTD. - 532523 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of the share certificate which has been reported as lost/misplaced from the custody of the shareholder.16-03-2024
BIOCON LTD. - 532523 - Announcement Under Regulation 30
Updated list of KMPs authorized to determine materiality of an event or information and make necessary disclosures to the Stock Exchange(s).14-03-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Resignation of Mr. Indranil Sen, Chief Financial Officer of the Company w.e.f. March 14, 2024.14-03-2024
Biocon Shares Rise On Rs 1,242 Crore Collaboration With Eris Lifesciences
The collaboration will help extend its existing partnership with Eris for Biocon's Nephrology and Dermatology business.14-03-2024
BIOCON LTD. - 532523 - Announcement Under Regulation 30
Biocon Biologics Limited, subsidiary of the company, has approved sale of its business in relation to its branded formulations in India to Eris Lifesciences Limited, on a ''slump sale'' basis.14-03-2024
BIOCON LTD. - 532523 - Announcement Under Regulation 30 (LODR)
Appointment of Senior Management Personnel.04-03-2024
Biocon shares gain on licence deal with Janssen, JJ for US markets
Biocon Share Price | In an another development, the company's subsidiary received observations from US Food and Drug Administration (USFDA).01-03-2024